NurExone Biologic Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	42	31	11	12	-
Market Cap Growth	39.67%	183.43%	-12.72%	-	-
Enterprise Value	41	28	10	9	-
Last Close Price	0.46	0.43	0.22	-	-
PB Ratio	28.88	17.35	57.03	5.89	-
P/TBV Ratio	28.88	17.35	57.03	5.89	-
Debt / Equity Ratio	0.05	0.02	6.44	0.01	0.89
Net Debt / Equity Ratio	-0.62	-0.38	3.58	-1.17	-0.99
Net Debt / EBITDA Ratio	0.14	0.14	-0.19	0.44	-
Net Debt / FCF Ratio	0.18	0.12	-0.22	0.63	0.95
Quick Ratio	1.28	2.08	0.34	4.17	1.67
Current Ratio	1.33	4.11	1.04	4.46	1.74
Return on Equity (ROE)	-298.06%	-517.23%	-318.51%	-499.17%	-
Return on Assets (ROA)	-129.23%	-135.79%	-92.09%	-123.02%	-
Return on Capital Employed (ROCE)	-362.80%	-245.20%	-1395.80%	-252.90%	-142.20%
Earnings Yield	-15.53%	-16.51%	-33.76%	-66.15%	-
FCF Yield	-12.27%	-18.13%	-28.40%	-31.58%	-
Buyback Yield / Dilution	-27.20%	-46.27%	-18.52%	-129.35%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.